Download PDF
CC BY-NC-ND 4.0 · Asian Journal of Oncology 2022; 08(03): 150-154
DOI: 10.1055/s-0042-1751121
Case Report

Dermatofibrosarcoma: Case Report Series

Ida B. M. Suryawisesa 
1   General Surgery and Oncologic Surgery Department, Faculty of Medicine, Udayana University/ Sanglah General Hospital, Denpasar, Bali, Indonesia
,
Oki P. Gotama
2   General Surgery Department, Faculty of Medicine, Udayana University/ Sanglah General Hospital, Denpasar, Bali, Indonesia
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Dermatofibrosarcoma protuberans (DFSP) is an uncommon, painless, slow-growth, superficial soft tissue malignant sarcoma corresponding to less than 0.1% of all malignancies. The primary treatment for DFSP is surgical excision, which is wide local excision (WLE) with tumor-free margins, Mohs micrographic surgery (MMS), and partial or total amputation. The goal of surgical excision is to achieve negative resection margins, thus reducing the local recurrence rate. These three cases reported large dermatofibrosarcoma, which began as a small nodule and progressed within approximately a year and were treated subsequently with wide excisions surgery. The unique and challenging part for most surgeons is removing the mass with a concentric excision due to its specific growth pattern. To achieve negative resection margins, the width of the tumor-free margins and infiltrating depth are two essential factors to be considered for complete excision for both WLE and MMS surgical techniques. Adjuvant therapy, including radiotherapy and targeted therapy, is reserved for unresectable, advanced stage, or recurrent tumors.

Keywords

dermatofibrosarcoma - wide local excision - Mohs micrographic surgery


Publication History

Article published online:
14 July 2022

© 2022. Spring Hope Cancer Foundation & Young Oncologist Group of Asia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Kreicher KL, Kurlander DE, Gittleman HR, Barnholtz-Sloan JS, Bordeaux JS. Incidence and survival of primary dermatofibrosarcoma protuberans in the United States. Dermatol Surg 2016; 42 (Suppl. 01) S24-S31
    CrossrefPubMedGoogle Scholar
  • 2 Stamatakos M, Fyllos A, Siafogianni A. et al. Dermatofibrosarcoma protuberans: a rare entity and review of the literature. J BUON 19 (01) 34-41 http://www.ncbi.nlm.nih.gov/pubmed/24659640 . Accessed June 2, 2022
    Google Scholar
  • 3 Nakamura I, Kariya Y, Okada E. et al. A novel chromosomal translocation associated with COL1A2-PDGFB gene fusion in dermatofibrosarcoma protuberans: PDGF expression as a new diagnostic tool. JAMA Dermatol 2015; 151 (12) 1330-1337
    CrossrefPubMedGoogle Scholar
  • 4 Madden C, Spector A, Siddiqui S, Mirkin G, Yim J, Hao X. Dermatofibrosarcoma protuberans on adult toes: a case report and review of the literature. Anticancer Res 2019; 39 (04) 2105-2111
    CrossrefPubMedGoogle Scholar
  • 5 Ritonga E. Profil Penderita Soft Tissue Tumor Di Laboratorium Patologi Rumah Sakit Advent Medan Tahun 2016–2017. J Univ Sumatera Utara 2020; 2 (18) 35-38
    Google Scholar
  • 6 Alnooh A, Qubaisy Y, Alshammari N, Alhowshan I. Dermatofibrosarcoma protuberans: a systematic review of the literature. Int J Med Dev Ctries 2020; 04 (11) 2014-2017
    Google Scholar
  • 7 Kornik RI, Muchard LK, Teng JM. Dermatofibrosarcoma protuberans in children: an update on the diagnosis and treatment. Pediatr Dermatol 2012; 29 (06) 707-713
    CrossrefPubMedGoogle Scholar
  • 8 Winarta GK, Suryawisesa IBM. Pitfall management of dermatofibrosarcoma protuberans on right leg. Int J Res Med Sci 2019; 7 (09) 3586 DOI: 10.18203/2320-6012.ijrms20193954.
    CrossrefGoogle Scholar
  • 9 Stivala A, Lombardo GAG, Pompili G, Tarico MS, Fraggetta F, Perrotta RE. Dermatofibrosarcoma protuberans: our experience of 59 cases. Oncol Lett 2012; 4 (05) 1047-1055
    CrossrefPubMedGoogle Scholar
  • 10 Hao X, Billings SD, Wu F. et al. Dermatofibrosarcoma protuberans: update on the diagnosis and treatment. J Clin Med 2020; 9 (06) 1752 DOI: 10.3390/jcm9061752.
    CrossrefPubMedGoogle Scholar
  • 11 Yoshida A, Tsuta K, Ohno M. et al. STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol 2014; 38 (04) 552-559
    CrossrefPubMedGoogle Scholar
  • 12 Goto H, Iwama Y, Kunisada M, Fujii M, Nisigori C, Sugimura K. Imaging features of dermatofibrosarcoma protuberans with pathologic correlation and assessments for recurrence potential. ECR Poster 2013
    Google Scholar
  • 13 Wiesmueller F, Agaimy A, Perrakis A. et al. Dermatofibrosarcoma protuberans: surgical management of a challenging mesenchymal tumor. World J Surg Oncol 2019; 17 (01) 90 DOI: 10.1186/s12957-019-1627-3.
    CrossrefPubMedGoogle Scholar
  • 14 Loghdey MS, Varma S, Rajpara SM, Al-Rawi H, Perks G, Perkins W. Mohs micrographic surgery for dermatofibrosarcoma protuberans (DFSP): a single-centre series of 76 patients treated by frozen-section Mohs micrographic surgery with a review of the literature. J Plast Reconstr Aesthet Surg 2014; 67 (10) 1315-1321
    CrossrefPubMedGoogle Scholar
  • 15 Kumar Diwakar D, Wadhwani N, Paruthi S. Recurrent dermatofibrosarcoma protuberans: challenging a surgeon's dexterity for the ‘tricky’ margins. Ecancermedicalscience 2018; 12 DOI: 10.3332/ecancer.2018.858.
    CrossrefPubMedGoogle Scholar